Kevin L. Cook
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kevin L. Cook
Kevin L. Cook was last confirmed as Board Member at Lineage Cell Therapeutics, Inc. (LCTX) in a filing dated April 29, 2022. Earlier roles on record: CFO at Lineage Cell Therapeutics, Inc. (LCTX) until July 8, 2022. Lineage Cell Therapeutics, Inc. reported in an 8-K filed July 7, 2022 that Kevin L. Cook resigned as Chief Financial Officer, effective July 8, 2022.
“On July 5, 2022, Kevin L. Cook notified Lineage Cell Therapeutics, Inc. ("Lineage") that he would be resigning as Chief Financial Officer of Lineage effective July 8, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-06-21–2022-07-08
-
2021-01-01–2022-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.